SynthesisAesthetic plastic surgery2026
Efficacy, Durability, and Safety of Collagen Biostimulators Based on Poly-L-Lactic Acid (PLLA) and Calcium Hydroxyapatite (CaHA) in the Face: A Systematic Review.
Synthesis in Aesthetic plastic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Cell Salvage in Liposuction, a Safety Tool in a New Surgical Scenario.Aesthetic plastic surgery · 2026Trial
- Diluted and Hyperdiluted Calcium Hydroxylapatite/Carboxymethylcellulose as a Technique Platform: A Narrative Review with Practical Taxonomy, Injection Mapping, and Safety.Aesthetic plastic surgery · 2026Review
- Monomorphous acneform lesions as an unusual early reaction to poly-L-lactic acid: Case report and management insight.JAAD case reports · 2026Article
- Regenerative Functional Microspheres for Aesthetic Medicine: Mechanism, Materials, Fabrication, and Clinical Applications.Advanced healthcare materials · 2026Review
- Expanding the Role of Cell Salvage: Implications for High-Volume Liposuction and Lipedema Surgery.Aesthetic plastic surgery · 2026Article
- Regeneration in Aesthetic Medicine: Mechanisms, Evidence, and Clinical Boundaries.Journal of cosmetic dermatology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCollagen biostimulators, such as poly-L-lactic acid (PLLA) and calcium hydroxyapatite (CaHA), are widely used in facial esthetic treatments to improve skin quality, restore volume, and stimulate neocollagenesis.
objectiveThis study aimed to evaluate the efficacy, durability, and safety of PLLA- and CaHA-based collagen biostimulators in facial esthetic treatments.
methodsA systematic literature review was conducted following PRISMA 2020 guidelines. The PICO strategy guided the research question. Searches were performed in April 2024 in the BVS, Medline (via PubMed), and Scopus databases, using standardized descriptors and Boolean operators. Studies published between 2010 and 2024, available in full text in Portuguese, English, or Spanish, were included. Screening was conducted using the Rayyan platform, and the quality of included studies was assessed with the ROB2 tool.
resultsFourteen studies met the eligibility criteria. Both PLLA and CaHA demonstrated significant improvements in skin elasticity, wrinkle reduction, and increased facial volume. PLLA maintained its effects for up to 25 months, while CaHA offered results lasting 12 to 18 months. The most frequent adverse effects were mild, including pain and swelling at the injection site. One serious case of compression necrosis was reported with CaHA.
conclusionBoth PLLA and CaHA are effective and safe biostimulators for facial rejuvenation. However, further research is needed to standardize techniques and assess long-term safety. LEVEL OF EVIDENCE I: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
41184662What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.